Literature DB >> 15657036

Molecular characterization of the human Calpha-formylglycine-generating enzyme.

Andrea Preusser-Kunze1, Malaiyalam Mariappan, Bernhard Schmidt, Santosh Lakshmi Gande, Kudzai Mutenda, Dirk Wenzel, Kurt von Figura, Thomas Dierks.   

Abstract

Calpha-formylglycine (FGly) is the catalytic residue in the active site of sulfatases. In eukaryotes, it is generated in the endoplasmic reticulum by post-translational modification of a conserved cysteine residue. The FGly-generating enzyme (FGE), performing this modification, is an endoplasmic reticulum-resident enzyme that upon overexpression is secreted. Recombinant FGE was purified from cells and secretions to homogeneity. Intracellular FGE contains a high mannose type N-glycan, which is processed to the complex type in secreted FGE. Secreted FGE shows partial N-terminal trimming up to residue 73 without loosing catalytic activity. FGE is a calcium-binding protein containing an N-terminal (residues 86-168) and a C-terminal (residues 178-374) protease-resistant domain. The latter is stabilized by three disulfide bridges arranged in a clamp-like manner, which links the third to the eighth, the fourth to the seventh, and the fifth to the sixth cysteine residue. The innermost cysteine pair is partially reduced. The first two cysteine residues are located in the sequence preceding the N-terminal protease-resistant domain. They can form intramolecular or intermolecular disulfide bonds, the latter stabilizing homodimers. The C-terminal domain comprises the substrate binding site, as evidenced by yeast two-hybrid interaction assays and photocross-linking of a substrate peptide to proline 182. Peptides derived from all known human sulfatases served as substrates for purified FGE indicating that FGE is sufficient to modify all sulfatases of the same species.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15657036     DOI: 10.1074/jbc.M413383200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  27 in total

1.  An alpha-formylglycine building block for fmoc-based solid-phase peptide synthesis.

Authors:  Jason Rush; Carolyn R Bertozzi
Journal:  Org Lett       Date:  2006-01-05       Impact factor: 6.005

2.  A general binding mechanism for all human sulfatases by the formylglycine-generating enzyme.

Authors:  Dirk Roeser; Andrea Preusser-Kunze; Bernhard Schmidt; Kathrin Gasow; Julia G Wittmann; Thomas Dierks; Kurt von Figura; Markus Georg Rudolph
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-20       Impact factor: 11.205

3.  SUMF1 mutations affecting stability and activity of formylglycine generating enzyme predict clinical outcome in multiple sulfatase deficiency.

Authors:  Lars Schlotawa; Eva Charlotte Ennemann; Karthikeyan Radhakrishnan; Bernhard Schmidt; Anupam Chakrapani; Hans-Jürgen Christen; Hugo Moser; Beat Steinmann; Thomas Dierks; Jutta Gärtner
Journal:  Eur J Hum Genet       Date:  2011-01-12       Impact factor: 4.246

4.  Sulfatase modifying factor 1 trafficking through the cells: from endoplasmic reticulum to the endoplasmic reticulum.

Authors:  Ester Zito; Mario Buono; Stefano Pepe; Carmine Settembre; Ida Annunziata; Enrico Maria Surace; Thomas Dierks; Maria Monti; Marianna Cozzolino; Piero Pucci; Andrea Ballabio; Maria Pia Cosma
Journal:  EMBO J       Date:  2016-12-01       Impact factor: 11.598

5.  HpSumf1 is involved in the activation of sulfatases responsible for regulation of skeletogenesis during sea urchin development.

Authors:  Tetsushi Sakuma; Kazuya Ohnishi; Kazumasa Fujita; Hiroshi Ochiai; Naoaki Sakamoto; Takashi Yamamoto
Journal:  Dev Genes Evol       Date:  2011-06-27       Impact factor: 0.900

6.  Downregulation of SUMF2 gene in ovalbumin-induced rat model of allergic inflammation.

Authors:  Chuanfeng Fang; Xiaoxia Li; Hongyan Liang; Li Xue; Lei Liu; Chun Yang; Guangqiang Gao; Xiaofeng Jiang
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

7.  Characterization of the human sulfatase Sulf1 and its high affinity heparin/heparan sulfate interaction domain.

Authors:  Marc-André Frese; Fabian Milz; Marina Dick; William C Lamanna; Thomas Dierks
Journal:  J Biol Chem       Date:  2009-08-07       Impact factor: 5.157

8.  Rapid degradation of an active formylglycine generating enzyme variant leads to a late infantile severe form of multiple sulfatase deficiency.

Authors:  Lars Schlotawa; Karthikeyan Radhakrishnan; Matthias Baumgartner; Regula Schmid; Bernhard Schmidt; Thomas Dierks; Jutta Gärtner
Journal:  Eur J Hum Genet       Date:  2013-01-16       Impact factor: 4.246

9.  Multiple sulfatase deficiency: clinical report and description of two novel mutations in a Brazilian patient.

Authors:  Osvaldo Alfonso Artigalás; Luiz Roberto da Silva; Maira Burin; Gregory M Pastores; Bai Zeng; Nívea Macedo; Ida Vanessa Doederlein Schwartz
Journal:  Metab Brain Dis       Date:  2009-08-21       Impact factor: 3.584

10.  Proprotein convertases process and thereby inactivate formylglycine-generating enzyme.

Authors:  Eva C Ennemann; Karthikeyan Radhakrishnan; Malaiyalam Mariappan; Michaela Wachs; Thomas H Pringle; Bernhard Schmidt; Thomas Dierks
Journal:  J Biol Chem       Date:  2013-01-03       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.